Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612001247864
Ethics application status
Approved
Date submitted
20/11/2012
Date registered
26/11/2012
Date last updated
26/11/2012
Type of registration
Prospectively registered

Titles & IDs
Public title
Learning from Consumers: Can Gynaecology Teaching Associates Deliver Effective Training for Medical Students?
Scientific title
A Single-Blinded Randomised Controlled Trial Evaluating the Role of Gynaecology Teaching Associates in Pelvic Examination Training of Medical Students - The GTA Trial.
Secondary ID [1] 281551 0
N/A
Universal Trial Number (UTN)
U1111-1137-1509
Trial acronym
The GTA Trial
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Pelvic Examination Training 287830 0
Condition category
Condition code
Reproductive Health and Childbirth 288177 288177 0 0
Other reproductive health and childbirth disorders
Public Health 288226 288226 0 0
Health promotion/education

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Gynaecology Teaching Associate Pelvic Examination Training

Single two and half hour session with two fully qualified and trained gynaecological teaching associates teaching pelvic examination. One gynaecological teaching associate as instructor and the second gynaecological teaching associate acting as a patient.
Intervention code [1] 286070 0
Other interventions
Comparator / control treatment
Routine pelvic examination training - lecture (1 hour faclitated by clinician) / access to pelvic examiniation models (self directed learning) / training within clinical settings (4 weeks)
Control group
Active

Outcomes
Primary outcome [1] 288377 0
Technical Competence
Timepoint [1] 288377 0
End of year examination
Secondary outcome [1] 300001 0
Communication and interpersonal skills
Timepoint [1] 300001 0
End of year examination
Secondary outcome [2] 300103 0
Knowledge of pelvic examination technique
Timepoint [2] 300103 0
End of obstetrics and gynaecology placement
Secondary outcome [3] 300104 0
Student anxiety
Timepoint [3] 300104 0
End of obstetrics and gynaecology placement
Secondary outcome [4] 300105 0
Reflective logbook of pelvic examination procedures
Timepoint [4] 300105 0
End of obstetrics and gynaecology placement

Eligibility
Key inclusion criteria
Undergraduate medical student
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
Declining participation within the trial

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation Concealment
Randomisation communicated within sequential, sealed, opaque envelopes
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Design
Single centre, individually randomised controlled trial.
Intervention and routine undergraduate’s education
or
Routine undergraduate education

Truly randomised, computer generated. Simple randomisation by using a randomisation table created by computer software (i.e., computerised sequence generation).
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 4683 0
United Kingdom
State/province [1] 4683 0
London

Funding & Sponsors
Funding source category [1] 286350 0
Charities/Societies/Foundations
Name [1] 286350 0
Barts and The London Charity
Country [1] 286350 0
United Kingdom
Primary sponsor type
University
Name
Queen Mary, University of London
Address
Mile End Rd
London Borough of Tower Hamlets
London
E1 4NS
Country
United Kingdom
Secondary sponsor category [1] 285138 0
None
Name [1] 285138 0
Address [1] 285138 0
Country [1] 285138 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 288433 0
Queen Mary, University of London Research Ethics Comittee
Ethics committee address [1] 288433 0
Ethics committee country [1] 288433 0
United Kingdom
Date submitted for ethics approval [1] 288433 0
Approval date [1] 288433 0
17/10/2012
Ethics approval number [1] 288433 0
QMREC2012/67

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 34961 0
Address 34961 0
Country 34961 0
Phone 34961 0
Fax 34961 0
Email 34961 0
Contact person for public queries
Name 18208 0
Dr James M N Duffy
Address 18208 0
Women’s Health Research Unit
Blizard Institute
58 Turner Street
London
E1 2AB
Country 18208 0
United Kingdom
Phone 18208 0
+44 79 5011 5547
Fax 18208 0
+44 20 7882 6047
Email 18208 0
Contact person for scientific queries
Name 9136 0
Dr James M N Duffy
Address 9136 0
Women’s Health Research Unit
Blizard Institute
58 Turner Street
London
E1 2AB
Country 9136 0
United Kingdom
Phone 9136 0
+44 79 5011 5547
Fax 9136 0
+44 20 7882 6047
Email 9136 0

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.